Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...
4h
News Medical on MSNLifestyle and environmental factors play bigger role in health and premature death than geneticsA new study led by researchers from Oxford Population Health has shown that a range of environmental factors, including lifestyle (smoking and physical activity), and living conditions, have a greater ...
Catherine Isted, an experienced healthcare CFO with over 25 years in life sciences, appointed as CFO effective February 24, 2025Current CFO ...
Esperto Medicalâ„¢, Inc. a healthtech startup specializing in critical care and remote patient monitoring, announces the ...
The category recognizes outstanding contributions in health equity, by life science companies or public sector organizations LONDON, Feb. 17, 2025 /PRNewswire/ -- The Galien Foundation ...
MPs scrutinising the assisted dying Bill will hear from England’s chief medical officer Professor Sir Chris Whitty as they meet for the first day of oral evidence on the proposed legislation.
Indeed, Quibim received FDA 510(k) clearance back in 2023 to market its QP-Prostate product; it also hired its first chief medical officer in the ... on the world of UK and European startups.
St. Luke's Medical Center has achieved another significant milestone, becoming the first and only hospital in the Philippines ...
Prof Sir Chris Whitty, England’s chief medical officer, warned MPs that implementing ... House of Commons/UK Parliament/PA Wire Ms Leadbeater’s Bill stipulates that the assisted dying service ...
St. Luke's Medical Center has achieved another significant milestone, becoming the first and only hospital in the Philippines to receive ...
Giving evidence to the UK Covid-19 Inquiry on 20 January,1 England’s chief medical officer, Chris Whitty, said that he had been personally sceptical about making covid vaccination a condition of ...
Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting Alluminoxâ„¢ platform-based photoimmunotherapy, today announced that it has completed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results